Quizartinib, a selective FLT3 inhibitor, maintains anti-leukaemic activity
A study published in the journal Oncotarget has reported a preclinical study, which has characterised the binding…
Browsing: FLT3 inhibitors
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- The OJC Episode 24
- New studies clarify which genes may raise breast cancer risk
- The State of Cancer in New Zealand 2020
- COVID-19 and Telehealth: Practical guide for cancer clinicians
- FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma
- Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
- Ultrasound technique treats prostate cancer with minimal side effects
- Landmark research toward increasing survival rates for aggressive childhood cancer
